Creating animal models to study gene variants linked to rare disorders
UAB Pilot Center for Precision Animal Modeling (C-PAM) - Coordination Section
This study is working to create animal models that help us understand how certain gene changes affect people with rare disorders, so we can learn more about the diseases and find better treatments for those who need them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10914824 on NIH RePORTER |
What this research studies
This research focuses on developing animal models to better understand the effects of specific gene variants found in patients with rare disorders. By utilizing advanced genome sequencing technologies, the team aims to identify and analyze these variants to determine their role in disease causation. The project involves a collaborative approach, bringing together experts in genetics, bioinformatics, and animal modeling to create accurate representations of these variants in animal models. This will help in exploring disease mechanisms and developing targeted therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with rare genetic disorders who have identified gene variants that may contribute to their condition.
Not a fit: Patients with common disorders or those without identified genetic variants may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with rare genetic disorders by providing insights into the pathogenicity of their specific gene variants.
How similar studies have performed: Previous research has shown success in using animal models to study genetic variants, indicating that this approach is promising and has the potential for significant advancements.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Yoder, Bradley K. — University of Alabama at Birmingham
- Study coordinator: Yoder, Bradley K.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.